Eva Rico Vidal
About Eva Rico Vidal
Eva Rico Vidal is a Senior Scientist at BenevolentAI in Cambridge, England, with a strong background in genome editing, functional genomic screening, and drug target identification.
Professional Experience at BenevolentAI
Eva Rico Vidal currently holds the position of Senior Scientist at BenevolentAI, based in Cambridge, England, United Kingdom. She is part of the Cell Engineering and Genetic Screening Team, contributing her extensive expertise in genome editing and functional genomic screening. Her role involves drug target identification and validation, focusing on infectious diseases and cancer.
Work History at Horizon Discovery
From 2019 to 2021, Eva Rico Vidal worked at Horizon Discovery as a Scientist in Cambridge, United Kingdom. During her tenure, she specialized in genome editing technologies and functional genomic screening. Her responsibilities included drug target identification and validation, contributing to Horizon Discovery's projects aimed at improving human health.
Research Role at University of Dundee
Eva Rico Vidal was a Molecular Biologist at the University of Dundee from 2017 to 2019 in Dundee, United Kingdom. Her work focused on the mechanisms of resistance in infectious diseases and cancer. She contributed to several research projects, enhancing the understanding of molecular pathways and their implications in disease.
Postdoctoral Research at The University of Edinburgh
From 2012 to 2017, Eva Rico Vidal served as a Postdoctoral Researcher at The University of Edinburgh in Edinburgh, United Kingdom. Her research concentrated on molecular and cell biology, where she made significant contributions to the field through her publication record. She also applied for and secured research funding while mentoring students and junior staff.
Educational Background at Universidad de Alcalá
Eva Rico Vidal completed her PhD in Biochemistry and Molecular Biology at Universidad de Alcalá, studying from 2005 to 2010. She also achieved a Bachelor of Science in the same field. In 2004, she undertook an undergraduate project in Oncology and Cancer Biology at the same institution. Her education laid a strong foundation for her career in scientific research.